The Positive Effect of Astocalm Plus on Stress Excitatory & Inhibitory Neurotransmitters

doi:https://doi.org/10.5281/zenodo.13883770

International Journal of Medical and Pharmaceutical Research

2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13883770

Original Research Article

The Positive Effect of Astocalm Plus on Stress Excitatory & Inhibitory Neurotransmitters

Aruna Vadivel, Gayathri R , Ranganathan S

DOI : https://doi.org/10.5281/zenodo.13883770

Published

March 10, 2024

Abstract

The present article describe the effect of a Astocalm plus tablet having anxiolytic effect proved by Monoamine Oxidase inhibition (MAO), Selective Serotonin Re-absorption Inhibition (SSRI), hippocampal region activation, neurite formation, GABAergic activity. The clinical validation has further proved the effect of the formulation in modifying salivary cortisol and salivary amylase in human volunteers during morning and noon hours. The herbs used in the formulation are extremely safe for oral usage. The details of the study findings and statistical significance established by U test and Sign test are presented in the article.

Recommended Articles

Volume-5, Issue-5

Downloads

Download PDF pdf

Download XML

Citations

1546 Views

267 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.